ZEO ScientifiX Selected for XPRIZE Healthspan Semi-Finals

Biotech firm advances in prestigious longevity competition

Apr. 7, 2026 at 7:37pm

An abstract, ghostly X-ray image revealing the complex internal structure of a human cell, conveying the scientific breakthroughs in longevity research.ZEO ScientifiX's innovative cellular therapies aim to unlock the secrets of human longevity by targeting the underlying mechanisms of aging.Davie Today

ZEO ScientifiX, a biotech company based in Davie, Florida, has been selected as a qualified team advancing to the semi-finals stage of the XPRIZE Healthspan competition. The XPRIZE Healthspan competition aims to accelerate innovations that extend the human healthspan, or the period of life spent in good health.

Why it matters

Winning the XPRIZE Healthspan competition could provide significant validation and funding for ZEO ScientifiX's research into longevity-enhancing therapies. As the population ages, there is growing demand for breakthroughs that can help people live longer, healthier lives.

The details

ZEO ScientifiX, a publicly-traded biotech firm, was selected as one of the qualified teams to advance to the semi-finals stage of the prestigious XPRIZE Healthspan competition. The competition challenges teams to develop innovative solutions that can dramatically extend the human healthspan. ZEO ScientifiX's proprietary therapies aim to slow the aging process and prevent age-related diseases.

  • The XPRIZE Healthspan competition was launched in 2025.
  • ZEO ScientifiX was selected as a semi-finalist in April 2026.

The players

ZEO ScientifiX, Inc.

A publicly-traded biotech company based in Davie, Florida that is developing longevity-enhancing therapies.

XPRIZE Foundation

A non-profit organization that designs and operates global competitions to solve humanity's grand challenges.

Got photos? Submit your photos here. ›

What they’re saying

“We are honored to be selected as a semi-finalist for the XPRIZE Healthspan competition. This recognition validates our team's tireless efforts to develop innovative solutions that can help people live longer, healthier lives.”

— Dr. Samantha Wilkins, CEO, ZEO ScientifiX

What’s next

ZEO ScientifiX will now advance to the semi-finals stage of the XPRIZE Healthspan competition, where they will compete for a share of the $10 million grand prize.

The takeaway

The selection of ZEO ScientifiX as an XPRIZE Healthspan semi-finalist highlights the growing importance of longevity research and the potential for innovative biotech companies to develop therapies that can dramatically extend the human healthspan.